ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has given the approval to the COVID-19 rapid testing kit.
The chief executive officer (CEO) of DRAP, Dr Asim Rauf, confirmed that a foreign pharmaceutical company has registered the coronavirus rapid testing kit which will provide the result of a nasal swab sample within 20 minutes.
Dr Rauf said the testing kits manufactured in Germany will be imported by a foreign pharmaceutical company and the initial testing fees will be charged up to Rs2,000. Only trained experts will be able to use the rapid testing kits and the results will be matched with the health condition and clinical history of patients, he added.
